The forecast for antihypertensive medicine sales in Italy reveals a steady value of 0.6 from 2024 to 2027 before a slight decline to 0.5 in 2028. This follows a status quo from 2023, indicating stability with minor fluctuations.

Year-on-year analysis of the forecast data suggests no variation until 2027, followed by a decrease in 2028. The Compound Annual Growth Rate (CAGR) over the last five years is negligible, reflecting consistent demand in the market.

Future trends to watch:

The prevalence of hypertension and related lifestyle diseases affecting market dynamics.
Advancements in healthcare technology potentially altering treatment protocols.
Impact of governmental healthcare policies on medication accessibility.